Market Overview:
The global methotrexate injection market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of cancer and other chronic diseases, rising demand for minimally invasive procedures, and technological advancements in the field of oncology. Based on type, the global methotrexate injection market can be segmented into preservative-free and with preservative. The preservative-free segment is expected to grow at a higher CAGR than the with preservative segment during the forecast period from 2018 to 2030. This growth can be attributed to factors such as increasing preference for minimally invasive procedures and growing awareness about adverse effects associated with use of preservatives in drugs. Based on application, the global methotrexate injection market can be divided into hospital, specialty clinic, and recovery center segments. The hospital segment is expected to dominate the global methotrexate injection market during the forecast period from 2018 to 2030 owingto rising incidence of cancer across all regions worldwide coupledwith growing numberof hospitals offering treatment services for cancer patients.
Product Definition:
Methotrexate Injection is a drug that is used to treat certain types of cancer, including leukemia, lymphoma, and osteosarcoma. It is also used to treat autoimmune diseases such as rheumatoid arthritis and psoriasis. Methotrexate works by blocking the action of enzymes that are involved in the growth of cancer cells and in the inflammation process.
Preservative-Free:
Preservative-free means the product is free from any preservatives. The products are manufactured in such a way that they do not contain any artificial additives or chemicals, and have not been chemically modified. They are produced by the addition of only two ingredients: methotrexate (MTX) and hydrochloric acid; which is then processed under controlled conditions to produce an injection for use as an anti-cancer drug.
The global Preservative-Free it's usage.
With Preservative:
With preservative is a mixture of salt and sugar used as anticoagulant in methotrexate injection. It helps to prevent the growth of bacteria which can cause toxic reaction in humans. With preservative contains glucose and sodium acetate trihydrate (SAT). Glucose is an simple sugar while SAT is a combination of amino acid, glucose, and sodium that help to preserve protein structure during processing & manufacturing methotrexate injection.
Application Insights:
On the basis of application, the market is segmented into hospital, specialty clinic and recovery center. Hospital was estimated as largest revenue-generating segment in 2017 due to increasing use of methotrexate for various indications in this setting. Increasing number of hospitals and surgeries across the globe has also positively influenced market growth. Moreover, growing awareness about availability of better treatment options for various diseases is further anticipated to boost industry growth over the forecast period.
Specialty clinics are expected to be fastest-growing application segment owing to rising preference for advanced treatment options by individuals suffering from chronic conditions or autoimmune disorders who require a higher dosage form than regular methotrexate injection can provide (recovery center).
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of patients suffering from cancer and methotrexate-resistant arthritis. The region is expected to maintain its dominance over the forecast period due to increasing R&D initiatives for new drug development, high healthcare expenditure, and growing adoption of cost-effective therapies.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising disposable income levels in emerging economies such as India & China, expanding patient pool suffering from rheumatoid arthritis & psoriasis as well as other chronic diseases that require long term treatment with low-cost drugs like methotrexate. These factors are expected favorably impact market growth during the forecast period.
Growth Factors:
- Increasing incidence of rheumatoid arthritis and other autoimmune diseases: The global Methotrexate Injection market is expected to grow at a CAGR of 5.5% during the forecast period, owing to the increasing incidence of rheumatoid arthritis and other autoimmune diseases.
- Rising demand for effective treatment options: The growing demand for effective treatment options is another key growth driver for the global Methotrexate Injection market.
- Technological advancements in drug delivery systems: The advent of novel drug delivery systems is also propelling the growth of the global Methotrexate Injection market. These systems offer improved patient compliance, safety, and efficacy profiles compared to traditional administration methods.
Scope Of The Report
Report Attributes
Report Details
Report Title
Methotrexate Injection Market Research Report
By Type
Preservative-Free, With Preservative
By Application
Hospital, Specialty Clinic, Recovry Center
By Companies
Hikma, Teva, Accord, Fresenius Kabi, Mylan, Pfizer, Get Well Pharmaceutical, Sichuan Huiyu Pharma, Youcare Pharmaceutical Group, Qilu Pharmaceutical, Shanxi Pude Pharma, Hengrui Medicine, Guangdong Lingnan Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
176
Number of Tables & Figures
124
Customization Available
Yes, the report can be customized as per your need.
Global Methotrexate Injection Market Report Segments:
The global Methotrexate Injection market is segmented on the basis of:
Types
Preservative-Free, With Preservative
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Specialty Clinic, Recovry Center
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Hikma
- Teva
- Accord
- Fresenius Kabi
- Mylan
- Pfizer
- Get Well Pharmaceutical
- Sichuan Huiyu Pharma
- Youcare Pharmaceutical Group
- Qilu Pharmaceutical
- Shanxi Pude Pharma
- Hengrui Medicine
- Guangdong Lingnan Pharma
Highlights of The Methotrexate Injection Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Preservative-Free
- With Preservative
- By Application:
- Hospital
- Specialty Clinic
- Recovry Center
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Methotrexate Injection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Methotrexate injection is a medication used to treat cancer. It works by stopping the growth of cancer cells. Methotrexate injection is usually given as an outpatient treatment.
Some of the major players in the methotrexate injection market are Hikma, Teva, Accord, Fresenius Kabi, Mylan, Pfizer, Get Well Pharmaceutical, Sichuan Huiyu Pharma, Youcare Pharmaceutical Group, Qilu Pharmaceutical, Shanxi Pude Pharma, Hengrui Medicine, Guangdong Lingnan Pharma.
The methotrexate injection market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Methotrexate Injection Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Methotrexate Injection Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Methotrexate Injection Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Methotrexate Injection Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Methotrexate Injection Market Size & Forecast, 2020-2028
4.5.1 Methotrexate Injection Market Size and Y-o-Y Growth
4.5.2 Methotrexate Injection Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Preservative-Free
5.2.2 With Preservative
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Specialty Clinic
6.2.3 Recovry Center
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Methotrexate Injection Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Methotrexate Injection Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Preservative-Free
9.6.2 With Preservative
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Specialty Clinic
9.10.3 Recovry Center
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Preservative-Free
10.6.2 With Preservative
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Specialty Clinic
10.10.3 Recovry Center
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Preservative-Free
11.6.2 With Preservative
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Specialty Clinic
11.10.3 Recovry Center
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Preservative-Free
12.6.2 With Preservative
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Specialty Clinic
12.10.3 Recovry Center
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Preservative-Free
13.6.2 With Preservative
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Specialty Clinic
13.10.3 Recovry Center
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Methotrexate Injection Market: Competitive Dashboard
14.2 Global Methotrexate Injection Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Hikma
14.3.2 Teva
14.3.3 Accord
14.3.4 Fresenius Kabi
14.3.5 Mylan
14.3.6 Pfizer
14.3.7 Get Well Pharmaceutical
14.3.8 Sichuan Huiyu Pharma
14.3.9 Youcare Pharmaceutical Group
14.3.10 Qilu Pharmaceutical
14.3.11 Shanxi Pude Pharma
14.3.12 Hengrui Medicine
14.3.13 Guangdong Lingnan Pharma
